Cerus Revenue Growth Rates (CERS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cerus Corporation  (NASDAQ: CERS)
 

CERS's Revenue Growth by Quarter and Year

Cerus's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CERS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 57.44
1st Quarter March 52.89
FY 110.33

CERSs Annual Revenue
Cerus's Revenue in the fiscal year 2025 $ 205.29 millions
Cerus's Revenue in the fiscal year 2024 $ 179.52 millions
Cerus's Revenue in the fiscal year 2023 $ 155.40 millions
Cerus's Revenue in the fiscal year 2022 $ 162.05 millions
Cerus's Revenue in the fiscal year 2021 $ 130.86 millions




CERS Revenue second quarter 2026 Y/Y Growth Comment
Cerus Corporation reported Revenue increase of 10.51% year on year in the second quarter 2026, to $ 57.44 millions, this is lower than Cerus Corporation's recent average Revenue improvement of 25.91%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 92 other companies have achieved higher Revenue growth. While Cerus Corporation' s Revenue growth of 10.51% ranks overall at the positon no. 1685 in the second quarter 2026.


CERS Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 14.32 % 8.72 % -55.65 %
3rd Quarter September - 15.35 % 16.43 % -36.86 %
2nd Quarter June 10.51 % 16.36 % 16.51 % -38.44 %
1st Quarter March 24.68 % 10.84 % 23.57 % -45.48 %
FY   - 14.35 % 15.53 % -

Financial Statements
Cerus's second quarter 2026 Revenue $ 57.44 millions CERS's Income Statement
Cerus's second quarter 2025 Revenue $ 51.98 millions Quarterly CERS's Income Statement


CERS Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 12.68 % 13.69 % 21.77 %
3rd Quarter September - 0.31 % 1.19 % 1.25 %
2nd Quarter June 8.6 % 22.54 % 16.72 % 23.8 %
1st Quarter March -9.97 % -17.45 % -19.04 % -70.94 %
FY (Year on Year)   - 14.35 % 15.53 % -


Back to CERS Growth rate Comparisons >> Back to CERS Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #93
Healthcare Sector #271
Overall #1685

Revenue Y/Y Growth Statistics
High Average Low
344.79 % 25.91 % -55.65 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #93
Healthcare Sector #271
Overall #1685
Revenue Y/Y Growth Statistics
High Average Low
344.79 % 25.91 % -55.65 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Cerus's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
317.11 % 10.59 % -70.94 %
(Dec 31 2017)  


CERS's II. Quarter Q/Q Revenue Comment
Cerus Corporation achieved in the II. Quarter 2026 below company average Revenue increase of 8.6% quarter on quarter, to $ 57.44 millions.

Within Medical Equipment & Supplies industry 36 other companies have achieved higher Revenue quarter on quarter growth. While Cerus's Revenue growth quarter on quarter, overall rank is 897.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #137
Overall #897
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #137
Overall #897
Revenue Q/Q Growth Statistics
High Average Low
317.11 % 10.59 % -70.94 %
(Dec 31 2017)  


CERS's II. Quarter Q/Q Revenue Comment
Cerus Corporation achieved in the II. Quarter 2026 below company average Revenue increase of 8.6% quarter on quarter, to $ 57.44 millions.

Within Medical Equipment & Supplies industry 36 other companies have achieved higher Revenue quarter on quarter growth. While Cerus's Revenue growth quarter on quarter, overall rank is 897.


Cerus's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 221.22 $ 215.76 $ 205.29 $ 197.92 $ 190.98
Y / Y Revenue Growth (TTM) 15.83 % 17.47 % 14.35 % 12.84 % 12.99 %
Year on Year Revenue Growth Overall Ranking # 991 # 1317 # 1138 # 1094 # 1057
Seqeuential Revenue Change (TTM) 2.53 % 5.1 % 3.72 % 3.63 % 3.98 %
Seq. Revenue Growth (TTM) Overall Ranking # 991 # 1317 # 1138 # 1094 # 1057


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Cerus's cumulative twelve months Revenue were $ 221 millions, company would post below average annual Revenue growth of 3.98% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Cerus's Revenue growth from the 183.67399999999998% growth in Mar 31 2026.

In the Healthcare sector 221 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 991, from total ranking in previous quarter at 1317.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 222
Overall # 1249

Revenue TTM Y/Y Growth Statistics
High Average Low
181.26 %
 20.24 %
-45.88 %
(Sep 30 2018)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 119
Sector # 324
S&P 500 # 2196
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Cerus's cumulative twelve months Revenue were $ 221 millions, company would post below average annual Revenue growth of -45.88% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Cerus's Revenue growth from the 183.67399999999998% growth in Mar 31 2026.

In the Healthcare sector 221 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 991, from total ranking in previous quarter at 1317.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 222
Overall # 1249

Revenue TTM Y/Y Growth Statistics
High Average Low
181.26 %
20.24 %
-45.88 %
(Sep 30 2018)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 119
Sector # 324
S&P 500 # 2196




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CERS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Lensar Inc 18.37%$ 18.371 millions
Immunocore Holdings Plc18.34%$ 18.336 millions
Innovage Holding Corp 18.31%$ 18.307 millions
Koru Medical Systems Inc 18.15%$ 18.153 millions
Clearpoint Neuro Inc 18.07%$ 18.068 millions
Avita Medical Inc 17.83%$ 17.830 millions
Xencor Inc17.46%$ 17.458 millions
Logicmark Inc17.39%$ 17.387 millions
Ensign Group Inc17.33%$ 17.325 millions
Medpace Holdings Inc 17.24%$ 17.242 millions
Geron Corporation17.22%$ 17.220 millions
Si bone inc 17.16%$ 17.159 millions
Cvrx inc 16.77%$ 16.766 millions
Regeneron Pharmaceuticals Inc 16.73%$ 16.735 millions
Invo Fertility Inc 16.73%$ 16.732 millions
Pro dex Inc 16.65%$ 16.646 millions
Royalty Pharma Plc16.50%$ 16.499 millions
Acadia Pharmaceuticals Inc 16.40%$ 16.402 millions
Harvard Bioscience Inc 16.35%$ 16.352 millions
Alpha Pro Tech Ltd 15.76%$ 15.765 millions
Armata Pharmaceuticals Inc 15.72%$ 15.722 millions
Lifeward ltd 15.71%$ 15.706 millions
Novocure Limited15.60%$ 15.603 millions
Ufp Technologies Inc 15.56%$ 15.558 millions
Orthopediatrics Corp15.55%$ 15.551 millions
Jazz Pharmaceuticals Plc15.55%$ 15.548 millions
Alphatec Holdings Inc 15.35%$ 15.349 millions
Penumbra Inc14.90%$ 14.904 millions
Rockwell Medical inc 14.69%$ 14.687 millions
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions


About Cerus Revenue Growth Rates (CERS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cerus Corp (CIK 1020214).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-326295
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cerus Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.